Your session is about to expire
← Back to Search
Omega-3 Nutritional Supplement
Omega-3 for Cataract
Phase 2 & 3
Waitlist Available
Led By Bradley Williams, MD
Research Sponsored by Physician Recommended Nutriceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This is a randomized, masked, placebo controlled study to assess the effect on visual acuity, if any, of the PRN omega-3 nutritional supplement in subjects undergoing cataract surgery.
Eligible Conditions
- Cataract
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Visual Acuity
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Omega-3Active Control1 Intervention
re esterified TG omega-3
Group II: Safflower OilPlacebo Group1 Intervention
vegetable oil
Find a Location
Who is running the clinical trial?
Physician Recommended NutriceuticalsLead Sponsor
4 Previous Clinical Trials
292 Total Patients Enrolled
Bradley Williams, MDPrincipal InvestigatorSouthern Eye Associates
1 Previous Clinical Trials
2 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger